BioMarin Pharmaceutical I...

NASDAQ: BMRN · Real-Time Price · USD
58.02
-0.28 (-0.48%)
At close: Aug 14, 2025, 3:59 PM
58.49
0.81%
After-hours: Aug 14, 2025, 07:52 PM EDT

BioMarin Pharmaceutical Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
942.84M 755.13M 724.53M 587.28M
Short-Term Investments
194.86M 318.68M 567.01M 426.6M
Long-Term Investments
521.24M 611.13M 333.83M 507.79M
Other Long-Term Assets
251.39M 125.46M 176.24M 151.76M
Receivables
660.53M 633.7M 461.32M 373.4M
Inventory
1.23B 1.11B 894.08M 776.67M
Other Current Assets
201.53M 141.39M 104.52M 110.44M
Total Current Assets
3.23B 2.96B 2.75B 2.27B
Property-Plant & Equipment
1.04B 1.11B 1.07B 1.04B
Goodwill & Intangibles
451.48M 490.9M 534.77M 584.85M
Total Long-Term Assets
3.76B 3.89B 3.62B 3.73B
Total Assets
6.99B 6.84B 6.38B 6B
Account Payables
235.4M 315.51M 231.24M 193M
Deferred Revenue
1.37M 4.62M 711K 6.96M
Short-Term Debt
n/a 493.88M n/a n/a
Other Current Liabilities
223.14M 150.52M 122.77M 123.74M
Total Current Liabilities
606.99M 1.18B 588.88M 539.82M
Long-Term Debt
595.14M 593.1M 1.08B 1.08B
Other Long-Term Liabilities
128.82M 119.94M 100.02M 79.84M
Total Long-Term Liabilities
723.96M 713.03M 1.18B 1.19B
Total Liabilities
1.33B 1.89B 1.77B 1.73B
Total Debt
602.71M 1.1B 1.08B 1.08B
Common Stock
191K 189K 186K 184K
Retained Earnings
-194.69M -621.55M -789.2M -925.69M
Comprehensive Income
61.65M -38.65M -3.87M 14.43M
Shareholders Equity
5.66B 4.95B 4.6B 4.27B
Total Investments
716.1M 929.82M 900.84M 934.39M